Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

Clinical Medicine logoLink to Clinical Medicine
. 2012 Dec;12(6):504. doi: 10.7861/clinmedicine.12-6-504

Genomic medicine: challenges and opportunities for physicians

H Burton, Cole T, AM Lucassen
PMCID: PMC5922586

Errors were introduced to Table 1 in this article during typesetting. The ‘Genetically predisposed subgroup’ cell of the breast cancer row should read ‘About 5% of cancers will be largely due to inheritance of a mutation in BRCA1 or BRCA2’, and the ‘Importance of molecular diagnosis in management’ cell of breast cancer should read ‘Further preventive management for breast cancer and/or ovarian cancer (eg mammography or MRI; prophylactic surgery of breasts and /or ovaries)’. The ‘Genetically predisposed subgroup’ cell of the bowel cancer row should read ‘About 5% of all cancers will be due, in large part, to inheritance of a mutated gene: eg familial polyposis, Lynch syndrome or MutYH polyposis’ and the ‘Importance of molecular diagnosis in management’ cell for bowel cancer should read ‘Consideration of other at-risk organs (eg uterus or ovaries in Lynch syndrome)’.

Table 1.

Common conditions and genetically predisposed subgroups.

graphic file with name clinmed-12-6-504tbl1.jpg

The corrected table is printed here.


Articles from Clinical Medicine are provided here courtesy of Royal College of Physicians

RESOURCES